In vitro Susceptibility of Madurella mycetomatis to the Extracts of Anogeissus leiocarpus Leaves

Authors: Ikram Mohamed Eltayeb Elsiddig, Abdel Khalig Muddather, Hiba Abdel Rahman Ali, Saad Mohamed Hussein Ayoub

Abstract:

Anogeissus leiocarpus (Combretaceae) is well known for its medicinal uses in African traditional medicine, for treating many human diseases mainly skin diseases and infections. Mycetoma disease is a fungal and/ or bacterial skininfection, mainly cause by Madurella mycetomatis fungus. This study was carried out in vitro to investigate the antifungal activity of Anogeissus leiocarpus leaf extracts against the isolated pathogenic Madurella mycetomatis, by using the NCCLS modified method compared to Ketoconazole standard drug, and MTT assay. The bioactive fraction was subjected to chemical analysis implementing different chromatographic analytical methods (TLC, HPLC, and LC-MS/MS). The results showed significance antifungal activity of A. leiocarpus leaf extracts against the isolated pathogenic M. mycetomatis, compared to negative and positive controls. The chloroform fraction showed the highest antifungal activity. The chromatographic analysis of the chloroform fraction with the highest activity showed the presence of important bioactive compounds such as ellagic and flavellagic acids derivatives, flavonoids and stilbenoid, which are well known for their antifungal activity.

Keywords: Anogeissus leiocarpus, crude extracts and fractions of Anogeissus leiocarpus, in vitro susceptibility of Madurella mycetomatis, Madurella mycetomatis.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1110211

References:

[1] Agaie, B.M.; Onyeyili, P.A.; Muhammad, B.Y. and Landan, M.J., 2007. Some Toxic Effects of Aqueous Leaf Extract of Anogeissus leiocarpus in rats. Journal of Pharmacology and Toxicology, 2(4): 396-401.
[2] Adejumobi, J.A.; Ogundiya, M. O.; Kolapo, A.andkunade, M.B., 2008. Phytochemical composition and in vitro antimicrobial activity of Anogeissus leiocarpus on some common oral pathogens. Journal of Medicinal Plants Research, 2(8):193-196.
[3] Okpekon, T.; Yolou, S.; Gleye, C.; Roblot, F.; Loiseau, P.; Bories, C.; Grellier, P.; Frappier F.; Laurens, A. and Hocquemiller, R., 2004. Antiparasitic activities of medicinal plants used in Ivory Coast. Journal of Ethnopharmacology, 90: 91-97.
[4] Agaie, B. M. and Onyeyili, P. A., 2007. Anthelmintic activity of the crude aqueous leaf extracts of Anogeissus leiocarpus in sheep. African Journal of Biotechnology, 6(13):1511-1515.
[5] Adeleye, I.A.; Ogunniyi, A.A. and Omonigbehin, E. A., 2003. Antimicrobial activity of some local herbs on common skin pathogens. Bioscience Research Communication, 15(3): 231-236.
[6] Vonthron-Sénécheau, C.; Weniger, B.; Ouattara, M.; Tra Bi, F.; Kamenan, A.; Lobstein, A.; Brun, R. and Anton, R., 2003. In vitro antiplasmodial activity and cytotoxicity of ethnobotanically selected Ivorian plants. Journal of Ethnopharmacology, 87: 221-225.
[7] Mustofa, V. A.; Benoˆıt-Vical, F.; Pellissier, Y.; Kone-Bamba, D. and Mallié, M., 2000. Antiplasmodial activity of plants extracts used in West African traditional Medicine. Journal of Ethnopharmacology, 73: 145- 151.
[8] Chaabi, M.; Benayache, S.; Vonthron-Sénécheau, C.; Weniger, B.; Anton, R. andLobstein, A., 2006. Antiprotozoal activity of saponins from Anogeissus leiocarpus (Combretaceae). Planta Med., 72: 7.
[9] Almagboul, A. Z.; Basher, A. and Salih, A.K. M., 1988. Antimicrobial activity of certain Sudanese plants used in folkloric medicine. Screening for antifungal activity. Fitoterapia, 59: 393-396.
[10] Mann, A.; Amupitan, J.O.; Oyewale, A.O.; Okogun, J.I.; Ibrahim, K.; Oladosu, P.; Lawson, L.; Olajide, I. and Nnamdi, A., 2008. Evaluation of in vitro antimycobacterial activity of Nigerian plants used for treatment of respiratory diseases. African Journal of Biotechnology, 7(11): 1630-1636.
[11] Ibrahim, M.B.; Owonubi, M.O.; Onaopo, J.A., 1997. Antibacterial effect of extract of leaf, stem and root bark of Anogeissus leiocarpus on some bacterial organisms. J. Pharm. Res. Dev., 2(1): 20-23.
[12] Sanogo, R., 2005. Antifungal and Antioxidant Activities of 14 plants used in the treatment of sexually transmitted infections. Afr. J. Trad, Complem. Alter. Med.,2(2): 177- 205.
[13] Batawila, K.; Kokou, K.; Koumaglo, K.; Gbéassor, M.; de Foucault,B.; Bouchet, Ph. and Akpagana, K., 2005. Antifungal activities of five Combretaceae used in Togolese traditional medicine. Fitoterapia, 76: 264-268.
[14] Mann, A.; Yahaya Y.; Banso, A. and Ajayi, G.O., 2008.Phytochemical and antibacterial screening of Anogeissus leiocarpus against some microorganisms associated with infectious wounds. African Journal of Microbiology Research, 2: 60-62.
[15] Mann, A.; Banso, A. and Clifford, L.C., 2008. An antifungal property of crude plant Extracts from Anogessius leiocarpus and Terminalia avicennioides, Tanzania Journal of Health Researc.,10(1): 34-38.
[16] Mann, A.; Amupitan, J.O.; Oyewale, A.O.; Okogun, J.I. and Ibrahim, K., 2009. Antibacterial activity of terpenoidal fractions from Anogeissus leiocarpus and Terminalia avicennioides against community acquired infections. African Journal of Pharmacy and Pharmacology, 3(1): 22-25.
[17] Mann, A.; Amupitan, J.O.; Oyewale, A.O.; Okogun, J.I. and Ibrahim, K., 2009. Chemistry of secondary metabolites and their antimicrobial activity in the drug development process: A review of the genus Anogeissus. Medicinal Plants-International Journal of Phytomedicines and Related Industries, 1(2): 6.
[18] Gumaa, S.A., 1994. The aetiology and epidemiology of mycetoma. Sudan medical journal, 32(2): 14-22.
[19] Mahgoub, E.S., 1994. Medical treatment of mycetoma. Sudan medical journal, 32(2): 88-97.
[20] NCCLS, 2002. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard NCCLS Document M38-A.9. National Committee for Clinical Laboratory Standards, Wayne, USA.
[21] Ahmed, A.O.; Van de Sande, W.W.; Van Vianen, W.; Belkum, Van Alex; Fahal, A.H.; Verbrug, H.A.; Irma, A. and Bakker-Woudenber, J.M., 2004. In vitro Susceptibility of Madurella mycetomatis to Itraconazole and Amphotericin B assed by a Modified NCCLS Method and a viability based 2,3-bis(2-methoxy 040nitro-5-sulfophenyl)-5- {(phenylamino) carbonyl}-2H-tetrazplium hydroxide (XTT) assay and a modified NCCLS method. Journal of Antimicrobial Chemotherapy, 48(7): 2742-2746.
[22] Van de Sande, W.W.J.; Lujendijk, A. and Ahmed, A.O., 2005.Testing of the in-vitro susceptibility of Madurella mycetomatis to six antifungal agents by using the sensititer system in comparison with viability based 2,3-bis(2-methoxy040nitro-5-sulfophenyl)-5-{(phenylamino) carbonyl}- 2H-tetrazplium hydroxide (XTT) assay and a modified NCCLS method. Journal of Antimicrobial Chemotherapy, 49:1364-1368.
[23] Muraina, I.A.; Picard, J.A. and Eloff, J.N., 2009. Development of a reproducible method to determine minimum inhibitory concentration (MIC) of plant extract against a slow-growing mycoplasmas organism. Phytomedicine, 16(2-3): 262-264.
[24] Kuo-Ching Wen, I-Chen Shih, Jhe-Cyuan Hu, Sue-Tsai Liao, Tsung- Wei Su, and Hsiu-Mei Chiang, 2011. Inhibitory Effects of Terminalia catappa on UVB-Induced Photodamage in Fibroblast Cell Line. Evid Based Complement Alternat Med.: 904532.
[25] Ten-Ning, C.; Guan-Jhong, H.; Yu-Lin, H.; Shgh-Shgun, H.; Heng-Yua, C.; Yuan-Shium, C., 2009. Antioxidant and Antiproliferative Activities of Crossostephium chinenis. The American Journal of Chinese Medicine, 37(4): 797-814.
[26] Eloff, J. N.; Katere, D. R.; McGaw, L.J., 2008. The biological activity and chemistry of the Southern African Combretaceae Journal of Ethnopharmacology, 119: 686-699.
[27] Reddy, K.K.; Rajadurai, S.; Sastry, K.N.S. and Nayudamma, Y., 1964. Studies on dhava tannins: Part I. The isolation and constitution of a gallotannin from dhava (Anogeissus latifolia). Australian Journal of Chemistry, 17(2): 238-245.
[28] Reddy, K.K.; Rajadurai, S. and Nayudamma,Y., 1965. Studies on Dhava (Anogeis suslatifolia) Tannins: Part III. Polyphenols of bark, sapwood and heartwood of Dhava. Indian. J. Chem., 27: 308-310.
[29] Deshpande, V.H.; Patil, A.D.; Rama Roa, A.V. and Venkataraman., 1976. Methylellagic acid and methylflavellagic acid from Anogeis suslatifolia bark, Ind. J. Chem., 14B: 641-643.
[30] Govindarajan, R.; Vijayakumar, M.; Rao, Ch.V.;Shirwaikar, A.;Rawat, A.K.S.; Mehrotra, S. and Pushpangadan, P., 2004. Antioxidant potential of Anogeissus. Biol. Pharm. Bull., 27(8): 1266-1269.
[31] Govindarajan, R.; Vijayakumar, M.; Rao, Ch.V.; Shirwaikar, A.; Pushpangadan, P. andMehrotra, S., 2004. Healing potential of Anogeissus latifolia for dermal wounds in rats. Acta. Pharmaceutica., 54(4): 331-338.
[32] Govindarajan, R.; Vijayakumar, M.; Shirwaikar, A.; Rawat A.K.S.; Mehrotra, S.and Pushpangadan, P., 2005. Activity Guided Isolation of Antioxidant Tannoid Principles from Anogeissus latifolia. Natural Product Sciences, 11(3):174-178.
[33] Pradeep, H.A.; Khan, S.; Ravikumar, K.; Ahmed, M.F.; Rao, M.S.; Kiranmai, M.; Reddy, D.S.; Ahamed, Sh.R.;and Ibrahim, M., 2009.Hepatoprotective evaluation of Anogeissus latifolia: In vitro and in vivo studies. World. J. Gastroenterol., 15(38): 4816-4822.
[34] Scalbert, A., 1991. Antimicrobial properties of tannins. Phytochemistry, 30: Pp 3875-3883.
[35] Cowan, M. M., 1999. Plant Products as Antimicrobial Agents. Clinical microbiology reviews, 12 (4): Pp 564-582.
[36] Langcake P., 1981. Disease resistance of Vitis spp. and the production of the stress metabolites resveratrol, e-viniferin, a-viniferin and pterostilbene. Physiological Plant Pathology,18: 312–226.
[37] Alessandro, M.; Marco, S.D.; Osti, F. and Cesari, A., 2000. Bioassays on the activity of resveratrol, pterostilbene and phosphorous acid towards fungal associated with esca of grape vine. Phytopathol. Mediterr., 39: 357-365.
[38] Alessandro, M.; Marco, S.D.; Osti, F. and Cesari, A., 2000. Bioassays on the activity of resveratrol, pterostilbene and phosphorous acid towards fungal associated with esca of grape vine. Phytopathol. Mediterr., 39: 357-365.
[39] Suh, N.; Paul, S.; Hao, X.; Simi, B.; Xiao, H.; Rimando, A.M. and Reddy, B.S., 2007. Pterostilbene, an active constituent of Blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats. Clin. Cancer Res., 13(1): 350-355.
[40] Rimando, A.M. and Suh, N., 2008. Biological/Chemopreventive Activity of Stilbenes and their Effect on Colon Cancer. Planta Med., 74(13): 1635-1643.